Portrait

BAS from Stanford, MD from Harvard Medical School and MIT

  • Professor of Neurosurgery, Director Surgical Neuro-Oncology at Cedars-Sinai Medical Center
  • Numerous patents for immunotherapies and nanotechnologies from his NIH funded laboratory
  • Developed 8 new investigational drugs with the FDA and has led numerous clinical trials
  • Most recently CEO and Chairman of AcTcell, and Director of Enviro Therapeutics
  • Immunology Fellowship at the Institute Pasteur, Paris, Neurosurgery Residency at Massachusetts General Hospital/Harvard

Portrait

M.S. and Sc.D. degrees in chemical engineering from MIT. MBA from the Wharton School of the University of Pennsylvania, where he graduated as a Palmer Scholar.

  • Global leader in the Life Sciences industry and is cofounder of the biomanufacturing company, Resilience (National Resilience, Inc.).
  • Former Operating Partner at Flagship Pioneering, where he founded and operated companies launched from Flagship’s innovation foundry, Flagship labs.
  • Former Chief Operating Officer of Takeda’s Vaccine Business Unit where he led worldwide vaccine CMC manufacturing.
  • Former President and CEO of Novavax, Inc. where he transformed the company from a specialty pharmaceutical business into a vaccine development company.
  • Career began at Merck & Co in 1994, where he held several positions in R&D and manufacturing.
  • Serves on the Board of Trustees of the Keck Graduate Institute, and on the Board of Directors for Codexis (Nasdaq:CDXS), and Garuda Therapeutics (private).

Portrait

BS in Biomechanics from Columbia, MD cum laude from Yale, former NIH Howard Hughes Research Fellow Bethesda, MD

  • Professor of Surgery in Orthopaedic Surgery at CSMC, Director of Education and clinical partner of the Orthopaedic Stem Cell and Tissue Engineering Laboratory
  • 10+ years experience in drug development, PI for 3-4 FDA-approved randomized clinical trials with over 30 clinical studies, 60+ published scientific papers, 5 review articles and 30 patents
  • Chief Medical Officer and Director of Prosidyan, Scientific Advisory Board Member of Mesoblast, Tissuegene, Spine Biopharma and Engage Surgical

Portrait

MD and Ph.D. in Neuroscience and Neurology from Cornell and Sloan Kettering (MSKCC), UCSF Health, Biomedical Fellow at Rockefeller and MSKCC

  • Senior ME for CBC Group, a healthcare-dedicated PE firm with over US$9 Billion AUM
  • 20+ year career as a physician, executive and institutional investor in US, Europe and Asia advising Eli Lilly, Bausch & Lomb, and Samsung Electronics/Biologics on Asian expansion, global drug development and commercial/partnership strategies
  • Former CEO of Genexine (KOSDAQ: 095700 w/ $1 Billion MC), led clinical development in Europe and Asia, raised $100M and created partnerships with Merck, Fosun Pharma, Tasly Pharma and Kalbe Pharma valued at over $250M
  • Former President of Catalyst Biosciences, (NASDAQ: CBIO) a clinical stage hemophilia and ophthalmology company partnered with Pfizer, MedImmune and Isu Abxis
  • Previous Board Chair of AffaMed Therapeutics and Director of Graybug Vision and InxMed
  • Board member of Hugel Inc (kosdaq: 145020.KQ)